Areas of Activity

Contact us


We wish to congratulate Dr. Gatkin, and his team, on their latest paper which was accepted for the upcoming 5th Meeting of the EAU Section of Urolithiasis (EULIS), which is being held on 3-5 October 2019, Milan, Italy.

A recent Meta-analysis, published in the International Urology and Nephrology Journal and authored by leading physicians from Kings College and University College in London, reviewed long-term efficacy of low-intensity shockwave therapy for Vasculogenic Erectile Dysfunction.

The study was presented at the American Urological Association Annual Scientific Meeting held May 3-6, 2019 at the McCormick Center in Chicago.  The study was performed by   Dr. Lu Mujun of Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai , China. 

In line with Direx Korea's objective to contribute to healthcare and develop strategic partnership with leading urologists, Direx Korea exhibited at Association of Korean Urologist Congress (Autumn) to announce the launch of Renova's Linear Shockwave Therapy for ED Treatment. "We hope to impact a change in the lives of those suffering from erectile dysfunction and enhance their quality of life" notes Byung Ki Kim, Manager of Direx Korea.

DirexGroup announced the conclusion of another highly successful conference at Medica last week (November 12-15) in Dusseldorf, Germany. 

DirexGroup, offering a full line of urological devices, will be launching Tempro, the unique bi-polar thermal therapy system for BPH treatment. Guest speaker, Byung Ki Kim, CEO of Korea, will be presenting each day at 2 pm the benefits of this effective treatment.

DirexGroup, the leading global company for urological devices, announces its participation in Congress of the Confederation American Urology (CAU). This four-day event will be held from October 30 – November 3 at the Punta Cana International Convention Center.

Some heavy-hitter urologists are testing a promising novel procedure known as shockwave therapy that could become a noninvasive, pill-free, game-changing fix in the treatment of erectile dysfunction (ED).ED is a frustrating condition that experts say affects some 50 percent of men between the ages of 40 and 70.

Niv Ein-Gal, VP Sales of Direx, attended Africa Health and presented Direx products offering unique and innovative urology-based solutions.

Ranjith Ramasamy, M.D., assistant professor of urology and director of reproductive urology at the University of Miami Miller School of Medicine, spoke recently before members of the American Urological Association at its annual convention in San Francisco. His presentation was a summary of randomized clinical trials he conducted on the effects of shockwave therapy for treating erectile dysfunction (ED), a chronic condition that affects 30 million men in the U.S.

Page 2 of 9

Contact Us

© 2017 DirexGroup. All Rights Reserved.